Video Experimental Relacionado
Updated: Sep 10, 2025
08:42
Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
550
Cáncer colorrectal y inmunoterapia
Farzad Teymouri1, Gagandeep Brar2
1Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA.
Cancer treatment and research
|August 23, 2025
Resumen
El cáncer colorrectal (CCR) afecta cada vez más a las personas más jóvenes. La inmunoterapia es prometedora, especialmente para pacientes con tumores de alta inestabilidad microsatélite (MSI-H) o deficiencia de reparación de desajuste (dMMR), con investigaciones en curso que exploran aplicaciones más amplias.
Área de la Ciencia:
- En el campo de la oncología
- Inmunología
- Biología molecular
Sus antecedentes:
- La incidencia del cáncer colorrectal (CRC) está aumentando a nivel mundial, con un aumento notable en la población más joven.
- La progresión del tumor implica vías moleculares complejas y estrategias de evasión inmunológica, lo que dificulta un tratamiento eficaz.
- El papel del sistema inmunológico en la vigilancia del cáncer es crítico, pero los tumores desarrollan mecanismos para evadir la detección y destrucción inmunológica.
Objetivo del estudio:
- Revisar el panorama actual de la inmunoterapia en el cáncer colorrectal.
- Para resaltar la eficacia de la inmunoterapia en subconjuntos genéticos específicos de CRC.
- Discutir las direcciones de investigación emergentes para ampliar el papel de la inmunoterapia en el tratamiento del CCR.
Principales métodos:
- Revisión de la literatura de ensayos clínicos y estudios de investigación sobre la inmunoterapia con CRC.
- Análisis de las vías moleculares y los mecanismos de evasión inmunológica en la CCR.
- Examen de los biomarcadores predictivos y estratificación de los pacientes para la respuesta a la inmunoterapia.
Principales resultados:
- La inmunoterapia ha demostrado beneficios clínicos significativos para los pacientes con cáncer colorrectal de alta inestabilidad microsatélite (MSI-H) o con deficiencia de reparación de desajuste (dMMR).
- Los agentes aprobados como el pembrolizumab y el nivolumab han demostrado eficacia en estas poblaciones de pacientes.
- La investigación está explorando la inmunoterapia en etapas tempranas de la enfermedad y en terapias combinadas, incluso en pacientes con biomarcadores negativos.
Conclusiones:
- La comprensión de las interacciones tumoral-inmunológicas es clave para avanzar en el tratamiento personalizado del CCR.
- La inmunoterapia representa un avance terapéutico significativo para un subconjunto de pacientes con CCR.
- La investigación futura tiene como objetivo ampliar la eficacia y la accesibilidad de la inmunoterapia a través de nuevos objetivos y estrategias de combinación.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K